Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Long-Term Investments (2015 - 2026)

Xencor (XNCR) posted quarterly Long-Term Investments of $157.4 million for Q1 2026, down 42.31% year-over-year from $272.8 million in Q1 2025, and down 10.37% quarter-over-quarter from $175.6 million in Q4 2025.

Analysis

Xencor (XNCR) Long-Term Investments (2015 - 2026) Analysis & Trends

Xencor (XNCR) has reported Long-Term Investments for 12 consecutive years, with $157.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Long-Term Investments fell 42.31% year-over-year to $157.4 million; the TTM figure through Mar 2026 stood at $157.4 million (down 42.31% YoY), while the FY2025 annual figure was $175.6 million, down 31.63% from the prior year.
  • Long-Term Investments declined to $157.4 million in Q1 2026 per XNCR's latest filing, from $175.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $290.3 million in Q3 2024 and bottomed at $31.1 million in Q2 2022.
  • Historically, Long-Term Investments has averaged $130.8 million across 5 years, with a median of $64.2 million in 2023.
  • Annual changes were most pronounced in 2022 — Long-Term Investments plunged 88.75% — and 2025, when it surged 526.3%.
  • Xencor's Long-Term Investments stood at $54.4 million in 2022, then jumped by 167.57% to $145.5 million in 2023, then soared by 76.5% to $256.8 million in 2024, then tumbled by 31.63% to $175.6 million in 2025, then decreased by 10.37% to $157.4 million in 2026.
  • Business Quant data shows XNCR's Long-Term Investments at $157.4 million in Q1 2026, $175.6 million in Q4 2025, and $247.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Xencor 2.02 Bn 1.65 Bn - 108.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.54 Mn
Mar 31, 2026 157.39 Mn
Dec 31, 2025 175.60 Mn
Sep 30, 2025 247.16 Mn
Jun 30, 2025 260.40 Mn
Mar 31, 2025 272.82 Mn
Dec 31, 2024 256.83 Mn
Sep 30, 2024 290.27 Mn
Jun 30, 2024 104.86 Mn
Mar 31, 2024 154.96 Mn
Dec 31, 2023 145.51 Mn
Sep 30, 2023 64.21 Mn
Jun 30, 2023 64.21 Mn
Mar 31, 2023 54.21 Mn
Dec 31, 2022 54.38 Mn
Sep 30, 2022 41.72 Mn
Jun 30, 2022 140.41 Mn
Mar 31, 2022 239.04 Mn
Dec 31, 2021 300.47 Mn
Sep 30, 2021 276.74 Mn